ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	1.12B +60.8%
Revenue (ttm)	109.99M -0.7%
Net Income	7.20M +55.6%
EPS	0.15 +75.1%
Shares Out	51.07M
PE Ratio	148.13
Forward PE	59.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,500
Average Volume	46,055
Open	22.50
Previous Close	22.00
Day's Range	22.50 - 22.70
52-Week Range	13.32 - 31.40
Beta	0.38
RSI	47.29
Earnings Date	Feb 12, 2026

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 53
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.